Literature DB >> 32572255

Epigenetic priming by Dppa2 and 4 in pluripotency facilitates multi-lineage commitment.

Mélanie A Eckersley-Maslin1, Aled Parry2, Marloes Blotenburg2,3, Christel Krueger2, Yoko Ito4, Valar Nila Roamio Franklin4, Masashi Narita4, Clive S D'Santos4, Wolf Reik5,6.   

Abstract

How the epigenetic landscape is established in development is still being elucidated. Here, we uncover developmental pluripotency associated 2 and 4 (DPPA2/4) as epigenetic priming factors that establish a permissive epigenetic landscape at a subset of developmentally important bivalent promoters characterized by low expression and poised RNA-polymerase. Differentiation assays reveal that Dppa2/4 double knockout mouse embryonic stem cells fail to exit pluripotency and differentiate efficiently. DPPA2/4 bind both H3K4me3-marked and bivalent gene promoters and associate with COMPASS- and Polycomb-bound chromatin. Comparing knockout and inducible knockdown systems, we find that acute depletion of DPPA2/4 results in rapid loss of H3K4me3 from key bivalent genes, while H3K27me3 is initially more stable but lost following extended culture. Consequently, upon DPPA2/4 depletion, these promoters gain DNA methylation and are unable to be activated upon differentiation. Our findings uncover a novel epigenetic priming mechanism at developmental promoters, poising them for future lineage-specific activation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32572255     DOI: 10.1038/s41594-020-0443-3

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  12 in total

1.  Am-bivalency towards DNA methylation.

Authors:  Eytan Zlotorynski
Journal:  Nat Rev Mol Cell Biol       Date:  2020-09       Impact factor: 94.444

2.  Mapping Phenotypic Plasticity upon the Cancer Cell State Landscape Using Manifold Learning.

Authors:  John G Lock; Smita Krishnaswamy; Christine L Chaffer; Daniel B Burkhardt; Beatriz P San Juan
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

3.  DPPA2 and DPPA4 are dispensable for mouse zygotic genome activation and pre-implantation development.

Authors:  Zhiyuan Chen; Zhenfei Xie; Yi Zhang
Journal:  Development       Date:  2021-12-21       Impact factor: 6.868

Review 4.  Interplay between chromatin marks in development and disease.

Authors:  Sanne M Janssen; Matthew C Lorincz
Journal:  Nat Rev Genet       Date:  2021-10-04       Impact factor: 53.242

Review 5.  Get Out and Stay Out: New Insights Into DNA Methylation Reprogramming in Mammals.

Authors:  Maxim V C Greenberg
Journal:  Front Cell Dev Biol       Date:  2021-01-07

Review 6.  Rebooting the Epigenomes during Mammalian Early Embryogenesis.

Authors:  Weikun Xia; Wei Xie
Journal:  Stem Cell Reports       Date:  2020-10-08       Impact factor: 7.765

7.  Maternal Dppa2 and Dppa4 are dispensable for zygotic genome activation but important for offspring survival.

Authors:  Oana Kubinyecz; Fatima Santos; Deborah Drage; Wolf Reik; Melanie A Eckersley-Maslin
Journal:  Development       Date:  2021-12-21       Impact factor: 6.868

8.  Epigenetic inheritance is gated by naïve pluripotency and Dppa2.

Authors:  Valentina Carlini; Cristina Policarpi; Jamie A Hackett
Journal:  EMBO J       Date:  2022-02-24       Impact factor: 11.598

9.  p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.

Authors:  Bradley D Weaver; Christina M Smith; Edward J Grow; Jingtao Guo; Paula Stein; Sean C Shadle; Peter G Hendrickson; Nicholas E Johnson; Russell J Butterfield; Roberta Menafra; Susan L Kloet; Silvère M van der Maarel; Carmen J Williams; Bradley R Cairns
Journal:  Nat Genet       Date:  2021-07-15       Impact factor: 38.330

10.  E2F6 initiates stable epigenetic silencing of germline genes during embryonic development.

Authors:  Thomas Dahlet; Matthias Truss; Ute Frede; Hala Al Adhami; Anaïs F Bardet; Michael Dumas; Judith Vallet; Johana Chicher; Philippe Hammann; Sarah Kottnik; Peter Hansen; Uschi Luz; Gonzalo Alvarez; Ghislain Auclair; Jochen Hecht; Peter N Robinson; Christian Hagemeier; Michael Weber
Journal:  Nat Commun       Date:  2021-06-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.